Related Experiment Video
Updated: Sep 4, 2025

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Artificial Intelligence in Cardiovascular Medicine: Current Insights and Future Prospects
Ikram U Haq1, Karanjot Chhatwal2, Krishna Sanaka3
1Department of Internal Medicine, Mayo Clinic, Rochester, MN, 55905, USA.
Artificial intelligence (AI) and machine learning (ML) offer scalable solutions for managing cardiovascular disease (CVD). Further validation is needed to integrate these powerful AI tools into clinical practice for better patient outcomes.
Failed At:
2026-06-19T13:39:37.878201+00:00
More Related Videos
07:51Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Imaging Studies for Cardiovascular System V: CT
Cardiovascular Drugs: Classification based on Therapeutic Indications